Gastrointestinal Stromal Tumor in a Patient with Neurofibromatosis Type 1 that Was Successfully Treated with Regorafenib

Akihito Fujimi, Yasuhiro Nagamachi, Naofumi Yamauchi, Fumito Tamura, Tomohiro Kimura, Naoya Miyajima, Hidetoshi Inomata, Takuji Nishisato, Makoto Yoshida, Kohichi Takada, Ko Kobayashi, Junji Kato
2019 Internal medicine (Tokyo. 1992)  
An unconscious 55-year-old man with a history of neurofibromatosis type 1 (NF1) was transported to the emergency department and was diagnosed with acute renal failure owing to a large bladder tumor. A submucosal tumor was also identified in the duodenum. The patient was diagnosed with a primary gastrointestinal stromal tumor (GIST) of the bladder and duodenum. After six cycles of regorafenib therapy, 18F-fluorodeoxyglucose accumulation in the duodenal GIST on positron emission
more » ... d tomography (PET-CT) showed a partial metabolic response. Currently, no standard drug therapy for unresectable or relapsed NF1-associated GIST has been established. Regorafenib may thus be considered as and appropriate initial therapy.
doi:10.2169/internalmedicine.2321-18 pmid:30918185 pmcid:PMC6663552 fatcat:y2nfxokiajdz3h7t6pk6fu2ari